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Abstract
The massively parallel computation of absolute binding free energy with a well-equilibrated
system (MP-CAFEE) has been developed [H. Fujitani, Y. Tanida, M. Ito, G. Jayachandran, C.
D. Snow, M. R. Shirts, E. J. Sorin, and V. S. Pande, J. Chem. Phys. 123, 084108 (2005)].
As an application, we perform the binding affinity calculations of six theophylline-related ligands
with RNA aptamer. Basically, our method is applicable when using many compute nodes to
accelerate simulations, thus a parallel computing system is also developed. To further reduce the
computational cost, the adequate non-uniform intervals of coupling constant λ, connecting two
equilibrium states, namely bound and unbound, are determined. The absolute binding energies
∆G thus obtained have effective linear relation between the computed and experimental values.
If the results of two other different methods are compared, thermodynamic integration (TI) and
molecular mechanics Poisson-Boltzmann surface area (MM-PBSA) by the paper of Gouda et al [H.
Gouda, I. D. Kuntz, D. A. Case, and P. A. Kollman, Biopolymers 68, 16 (2003)], the predictive
accuracy of the relative values ∆∆G is almost comparable to that of TI: the correlation coefficients
(R) obtained are 0.99 (this work), 0.97 (TI), and 0.78 (MM-PBSA). On absolute binding energies
meanwhile, a constant energy shift of ∼ -7 kcal/mol against the experimental values is evident. To
solve this problem, several presumable reasons are investigated.
∗Electronic address: tanida@labs.fujitsu.com
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I. INTRODUCTION
To accurately compute the free energy difference between two thermal equilibrium states
(∆G) is of interest in computational science and of importance in terms of drug discovery [1].
It can help us obtain a quantitative understanding of molecular complexes from atomic-scale,
and also provide valuable information for use in structural refinement for drug design. Gen-
erally speaking, to discuss chemical reaction, we have to determine the free energy change
within so-called chemical accuracy (∼ 1 kcal/mol), which is very challenging. Popularly,
several free energy calculations have been carried out within the framework of the thermal
equilibrium approach. For instance, free energy perturbation (FEP) [2] and thermodynamic
integration (TI) [3] have been widely used to calculate the free energy change associated
with the transformation of one ligand into another via thermodynamic cycles [4, 5]. Cer-
tainly, the recent improvement in these methods and the increase in computer resources
have enabled us to calculate the absolute binding energy concerned with very small organic
compounds [6, 7, 8, 9]. However, equilibrium approaches involving most rigorous technique,
known as the double decoupling method, require long time simulation to maintain the re-
versibility about the work associated with the decoupling process. As a more approximate
method, the molecular mechanics Poisson-Boltzmann surface area (MM-PBSA) analysis [10]
has been a popular method to obtain absolute binding free energies within a reasonable time.
In this approach, explicit waters and mobile counter ions are treated by the continuum model
after obtaining the molecular dynamics (MD) trajectory. Since the normal mode analysis
is time-consuming, the contribution of solute entropy is often approximated based on the
average of a few snapshots. On the other hand, in the nonequilibrium statistical approach,
Jarzynski recently derived a nonequilibrium work theorem that is valid in far from equilib-
rium regime [11, 12, 13, 14, 15, 16, 17, 18], although accurate numerical estimates of the
exponential average, based on a finite number of sampled works, are relatively difficult [19].
Shirts et al. proposed the acceptance ratio (AR) method [20, 21, 22, 23] to estimate the
free energy difference and also calculated the binding free energies for eight FKBP12-ligand
complexes [24] using the “folding@home” system. Furthermore, our previous work [25] sug-
gested the efficiency of the use of general AMBER force field (GAFF) [26] for ligands to
obtain the predictive binding estimates, and simultaneously indicated the importance of
starting structures for simulations. In our method the use of many independent compute
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nodes or a grid computing system is effective to accelerate simulations, whereupon we also
developed a massively parallel computing system, “BioServer”, consisting of 1920 micropro-
cessor elements, to efficiently perform the binding free energy calculations. Hereafter, our
method is referred to as the massively parallel computation of absolute binding free energy
with a well-equilibrated system (MP-CAFEE).
The principal aim of this study is to explore the practical feasibility of our methodology,
based on a nonequilibrium approach. We have performed the calculation of the absolute
binding free energy for theophylline and its analogs to the RNA aptamer. On the same
system, Gouda et al. reported the results of free energy calculations using two different
methods, TI and MM-PBSA [27]. Therefore, this system is a good platform to compare
the ability between two different methods, namely the equilibrium and nonequilibrium ap-
proach. The paper is organized as follows. We initially describe the theoretical background
and simulation protocol of binding free energy estimation used through this work, before
subsequently explaining the choice of coupling constant λ intervals connecting two equilib-
rium states in Sec. II. The results for all RNA-ligands are presented and discussed in Sec.
III. After pointing out the key features of this system, we conclude in Sec. IV.
II. COMPUTATIONAL DETAILS
In general, the methods used to calculate the free energy difference in molecular sim-
ulations can be classified as either equilibrium or nonequilibrium approaches. Several ap-
proaches based on thermal equilibrium, e.g. FEP, TI and the potential of mean force using
weighted histogram analysis method with umbrella sampling [28], have been attempted to
compute the free energy difference between two equilibrium states. However, the equilibrium
approaches encounter the difficulty of removing the nonequilibrium contributions, known as
the hysteresis problem [29, 30, 31]. In order to overcome this difficulty, a long time simu-
lation must be performed, to retain the reversibility of quasistatic process associating with
the thermal equilibrium. Recently, Jarzynski’s equality exactly relates the free energy dif-
ference of two equilibrium states i and j to the statistics of works via a nonequilibrium,
irreversible process that connects them as exp(−∆G/kBT ) = 〈exp(−W/kBT )〉, where W is
the work change of a system from i to j under isothermal isobaric (NPT) conditions [32]. A
remarkable feature of Jarzynski’s equality is the fact that the switching time between two
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states is arbitrary. Subsequently, when the process occurs instantaneously, the work can be
defined by the potential energy difference as W ≡ U(λj,x) − U(λi,x), where U and x are
the potential function and configurational coordinates, respectively. A coupling constant λ
is imposed on the path connecting two states. The fluctuation theorem (FT) related with
Pi→j(W ) and Pj→i(W ) of the work probability distributions along the non-equilibrium for-
ward (i→ j direction) and reverse (j → i direction) processes is derived by Crooks [13] as
Pi→j(+W )/Pj→i(−W ) = exp[(W −∆G)/kBT ]. The ratio between Pi→j(+W ) and Pj→i(−W )
depends only the value of the free energy difference ∆G. Shirts et al. pointed out that
the maximum likelihood ∆G is given by AR analysis, namely, the control parameter in
AR analysis must correspond to the free energy difference [21]. Since two irreversible work
distributions in forward and reverse directions cross at W= ∆G, both distributions must
have a large overlap to obtain the free energy estimate with high accuracy. Subsequently,
after applying the multi-staging method, the intermediate stages are inserted onto the path
between two states i and j, with the total free energy change obtained as the sum of the
differences. This type of usage, involving the insertion of many intermediate states on the
path connecting two states, seems to be effective. However, since economical issues also play
a role because many λ require significant computing resources, we have now addressed the
issue concerned with determining the adequate choice of each λ interval. First, potential
energy is parameterized by λ, followed by the introduction of the λ dependency to the non-
bonded interactions. In order to avoid instability near the end-points of the vanishing atoms
through calculation, the non-bonded interaction energy U(λC, λLJ) between the ligand and
others, including the so-called soft-core potentials, is used [33]. We also use two kind of
coupling constant λ for representing two different potential energies: the fully bound state
(λC = λLJ = 0) and the unbound state (λC = λLJ = 1). Hereafter, the free energy compo-
nent resulting from turning off the electrostatic potential (λC = 0 → 1, λLJ = 0) is referred
as the electrostatic contribution. We also denote the free energy component for the process
of (λC = 1, λLJ = 0→ 1) as the van der Waals contribution. Next, we investigate the conver-
gence properties of the free energy when the number of equal λ spacings (≡ N) increases. A
trajectory at each intermediate λi is obtained via the standard MD simulation. As already
noted, the work associated with the forward path is obtained to compute the potential energy
difference as WF(i, i+ 1) = U(λi+1,xi)− U(λi,xi). Using a trajectory at λi+1, the work on
the reverse path is also obtained as WR(i, i+1) = U(λi+1,xi+1)−U(λi,xi+1), while the free
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energy ∆Gi,i+1 can be estimated using both work distributions ofWF(i, i+1) andWR(i, i+1)
by the AR algorithm, thus the free energy difference is ∆G =
∑N−1
i=0 ∆Gi,i+1. In general, ∆G
is being converged as the number of N increases. N0 is defined as a large enough number to
obtain the well-converged value of ∆G (≡ ∆G0). We also define ∆G(λn) =
∑n−1
i=0 ∆Gi,i+1.
Finally, to reproduce the feature of ∆G0(λn), the adequate mesh points of λ are determined
to be satisfied with the following requirements: 1) the small difference between ∆G and
∆G0; 2) the small root mean square (rms) error between ∆G(λn) and ∆G0(λn). The rms
error used here is defined as
[
(1/N)
∑N−1
i=0 | ∆G(λi)−∆G0(λi) |
2
]1/2
.
Now, we have applied this manner to an RNA-theophylline system. Using the first 100
ps MD simulation N0 were determined as 20 for electrostatic contribution and 40 for van
der Waals contribution respectively. As can be seen from Table I, we have determined the
non-uniform mesh points of λ with ∆G difference (≡ δG) ≤ 0.05 kcal/mol and rms error
of ∆G(λ) ≤ 0.1 kcal/mol, leading to a significant reduction in the number of necessary λ
points. The λ points obtained were the following: 12 values of λC points (0, 0.1, 0.25, 0.45,
0.55, 0.65, 0.7, 0.75, 0.8, 0.9, 0.95, 1) and 21 values of λLJ points (0, 0.1, 0.2, 0.275, 0.375,
0.45, 0.55, 0.65, 0.675, 0.725, 0.75, 0.775, 0.8, 0.825, 0.85, 0.875, 0.9, 0.925, 0.95, 0.975, 1).
Computed ∆G(λi) as a function of λi were also shown in Figs. 1(a) and (b). It is clear that
the feature of the well-converged curves is reproduced well by a small number of non-uniform
mesh points.
To estimate the free energy difference, the path from the bound state (λ= 0) to the
unbound state (λ= 1) is chosen as follows; the ligand electrostatic interactions with the
environment are turned off, followed by its van der Waals interactions with the environment,
whereupon we obtain the solvation energy of ligand as ∆GSolv (≡ ∆G
C
Solv+∆G
LJ
Solv). The free
energy of the annihilation of the ligand from the ligand-receptor complex (complexation free
energy) is also calculated as ∆GComplex (≡ ∆G
C
Complex +∆G
LJ
Complex). We schematically note
as follows; L(sol) → L(gas) on the calculation of the solvation free energy of the ligand (L) and
RL(sol) → R(sol)+L(gas) on the calculation of the complexation free energy of the ligand (L) to
the receptor (R). Consequently, we obtain the absolute binding free energy of the receptor-
ligand complex as ∆G ≡ ∆GComplex −∆GSolv = ∆G
C
Complex +∆G
LJ
Complex −∆G
C
Solv −∆G
LJ
Solv
using the relation of RL(sol) → R(sol) + L(sol).
In our study the three-dimensional structure of the RNA-theophylline complex proposed
by Clore et al. [34] (PDB code 1O15) was used as a modeling. We assumed that the bind-
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ing sites for six ligands fit into the structural framework of the original RNA-theophylline
structure because the structures of other complexes were not experimentally determined.
All MD simulations were performed using a modified version of the GROMACS package
(v3.1.4) [35] with single precision to speed up the execution. The Amber force field pa-
rameters (ff99) were used to describe the RNA aptamer, including 1-4 interactions between
hydrogen atoms, while the force field parameters for Mg2+ ions [36] were also used from
the Amber package. The atomic structure of the theophylline molecule was optimized in a
vacuum using Gaussian 98 (Gaussian, Inc.) with the HF/6-31G∗ single-point energy calcu-
lation, while the atomic charges were calculated using the restrained electrostatic potential
(RESP) method [37] and the ANTECHAMBER program was used to assign the GAFF for
each atom. The chemical structures of the ligands investigated here are shown in Fig. 2,
while the electrostatic potential surface of these molecules, computed using the Adaptive
Poisson-Boltzmann Solver (APBS) package [38] after using the RESP charge fitting are also
shown. It is clear that hypoxanthine has a slightly different charge distribution around the
lower left-hand side of the molecule as compared to other molecules. The TIP3P model for
water molecules was used to describe the solvent [39].
Through this study we obeyed the following parameters for all MD simulations. Integra-
tion of the equation of motion was performed using the leap-frog algorithm and all bonds
were constrained by LINCS [40] with order 8. We used the time step of 2.0 fs while the non-
bonded pair list of 1 nm was updated every 10 steps. All simulations were carried out at T=
298 K using the Nose-Hoover [41, 42] temperature control and at 1 atm using the Berend-
sen [43] pressure control respectively, with a time constant of 0.5 ps and a compressibility of
4.5×10−5 bar−1. The particle mesh Ewald (PME) [44] summation was used to evaluate the
electrostatic interactions with a grid spacing of approximately 0.12 nm, a cubic spline order
of 4 and relative tolerance between long and short range energy of 10−8. The L-J interaction
energy was calculated by a switched cutoff between 0.8 nm and 0.9 nm. We also included
long range correction to the energy and pressure. We used the truncated octahedron box
as a unit cell with periodic boundary conditions, while for the solvated ligand system, we
adopted the unit cell size, maintained no closer than 0.85 nm from each face of the box,
and introduced about 238 to 282 TIP3P water molecules into the unit cell. RNA-ligand
complexes were prepared in which the minimum distance was 0.75 nm between the nearest
unit cell wall on either side, while the number of TIP3P water molecules used were either
6
7192 or 7193. We introduced 3 Mg2+ ions into the complex according to the paper of Gouda
et alt [27, 45, 46] and also added 26 Na+ counter-ions to the complex to neutralize the
system.
One of the difficulties for computing the binding free energy is the preparation of start-
ing structure sampled from the canonical ensemble at the desired temperature T [25]. The
following procedure was used. We performed energy minimization using the conjugate gra-
dient method, followed by the MD simulation of 20 ps relaxation with the solute positions
restrained. In order to attain the thermal equilibrium state (λC=λLJ= 0), 10/15 ns MD
calculations were typically used for the solvated ligand and the RNA-ligand complexes.
Through this process, used to conclude the system to be equilibrated, the total potential
energy of the system and the local electrostatic and van der Waals potential energies be-
tween RNA and ligand were carefully monitored. Via the multi-stage method we adopted an
atomic structure at λ= 0 after completing the preconditioning MD simulation as a starting
structure at each intermediate λ state. To decrease the uncertainty from statistical error,
we sampled the MD simulation with 15 and 10 kinds of different initial velocities for the
solvated ligand system and RNA-ligand complex, respectively. Nonequilibrium works ev-
ery 50 steps (0.1 ps) were used to compute the free energies, which were obtained as the
arithmetic average of all estimated values. Through this work we simultaneously performed
330 (33 independent non-uniform λ points × 10 samples) independent MD simulations to
generate the energetically possible samples for evaluating the binding free energy on the
Fujitsu BioServer system, consisting of 1920 FR-V microprocessors.
III. RESULTS AND DISCUSSION
It was found that a Mg2+ ion shielded by water molecules and located at the center of
the U-turn formed by C22-U24 [46] remained unchanged during all the preconditioning MD
simulations. Conversely however, other Mg2+ ions immediately left their initial positions,
and diffused around an RNA aptamer.
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A. Theophylline
A 15 ns preconditioning MD simulation was used to reach a thermal stable structure
in the RNA-theophylline complex. We now consider the energetically favorable structure
from the perspective of both electrostatic interaction and that of van der Waals. The
obtained structure is consistent as expected, namely, the negative surface region of an RNA
strongly interacts with the positive region on a complementary molecule surface. Besides,
there is a match of theophylline and residue of A28 on the substrate. This result can be
interpreted based on the view that the van der Waals interaction simultaneously stabilizes
the theophylline molecule onto the binding pocket. Furthermore, theophylline is bound with
an upper as well as lower layer.
Let us now move on to the binding free energy calculation to examine the availability
of our method. The open circles in Fig. 3 show the features of the convergence of (a) the
solvation free energy of theophylline and of (b) the complexation free energy of theophylline
to an RNA as a function of the MD step. Each open circle was obtained by analyzing the
generated works during each 100 ps MD trajectory. Rough convergence appears visible after
200 ps and 700 ps for (a) the solvated ligand and (b) the solvated RNA-ligand complex,
respectively. Subsequently, we used work values from 200 ps to 1 ns (8000 samples) to
estimate the solvation energy ∆GSolv and those from 700 ps to 1 ns (3000 samples) to
estimate the complexation energy ∆GComplex, and obtained -14.4 kcal/mol for ∆GSolv and
-30.5 kcal/mol for ∆GComplex. Consequently, we also obtained the binding free energy ∆G
of -16.1 kcal/mol for the RNA-theophylline system. We have summarized the free energy
components in Table II and it can be found that the favorable structure of this complex is
mainly driven by the van der Waals interaction.
We further comment on the computational cost required to obtain the converged ∆G.
Since the ratio of the simulation time between the solvation and complexation is relatively
small, we only consider the simulation time for obtaining ∆GComplex. In this system, a total
of 330 ns MD simulations for obtaining ∆GComplex were used. However, our approach is
applicable for the use of many compute nodes to accelerate calculations, meaning the use
of a parallel computing system, including a grid environment, is the key to diminishing the
computation turnaround time.
B. Caffeine
Caffeine differs from theophylline by a single methyl group as shown in Fig. 2. Each
component, once decomposed from estimated binding energies, was tabulated in Table II.
It is evident that the significant difference of 5.1 kcal/mol between the theophylline and
caffeine bindings is mainly attributable to the electrostatic contribution (4.6 kcal/mol). We
now address and attempt to explore the reason why the affinity between RNA and caffeine
is drastically reduced in comparison with that between RNA and theophylline. Due to the
typical snapshots, both ligands preferably bind within the pocket of an RNA, as illustrated
in Figs. 4(a) and (b). Hereafter, we discuss the results during 1ns MD simulations after
reaching thermal equilibrium states for both systems. The obtained averaged distances of
TEP(O)-C22(1H4), TEP(hn)-C22(N3), TEP(hn)-C22(O2) and TEP(nc)-U24(H3) are 0.22
nm, 0.19 nm, 0.26 nm and 0.21 nm, respectively, while the averaged distance of CAF(nc)-
U24(H3) of 0.21 nm was also obtained for the RNA-caffeine complex. These values indicated
the creation of hydrogen bonds as the bond lengths were less than approximately 0.25 nm.
This difference in the number of hydrogen bonds between both RNA-caffeine and RNA-
theophylline complexes may result in a significant difference in the binding energy, so the
number of hydrogen bonds for both systems were enumerated. At this point, we determined
the hydrogen bond based on the cutoff angle of the donor-hydrogen-acceptor and the distance
of the hydrogen-acceptor; values of 60◦ for cutoff angle and 0.25 nm for cutoff distance were
used. We obtained hydrogen bonds of 4.3 (±1.0) for the solvated caffeine and the numerical
value in parentheses indicated the standard deviation. On the other hand, the solvated
theophylline has 5.4 (±1.1) hydrogen bonds. These results indicated a decrease in the
hydrogen bond in solvated caffeine as compared to the solvated theophylline. The number
of hydrogen bonds for the solvated RNA-caffeine complex were 2.8 (±0.8) and 0.9 (±0.2) for
caffeine-water and RNA-caffeine pairs. We also counted the number of hydrogen bonds for
the solvated RNA-theophylline complex: 2.3 (±0.7) for theophylline-water and 3.1 (±0.6)
for RNA-theophylline. This value (∼ 3) is easily understood as the hydrogen atom TEP(hn)
are shared to be bound by both a nitrogen atom (C22(N3)) and an oxygen atom (C22(O2))
in the solvated RNA-theophylline complex as shown in Fig. 4(a), while these hydrogen bonds
vanish in the solvated RNA-caffeine complex in Fig. 4(b). The hydrogen bond contributing
to binding energy for the RNA-theophylline system is ∼ 0, while the decrease in the number
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of hydrogen bonds for the RNA-caffeine system is ∼ 0.6. The contribution energies to
binding free energies are roughly ∼ 0 kcal/mol for the RNA-theophylline system and ∼ 3.6
kcal/mol for the RNA-caffeine system, based on a presumed hydrogen bond energy of ∼ 6
kcal/mol. Therefore, the decrease in the hydrogen bonds represents the main reason for the
significant difference in affinity between the RNA-theophylline and RNA-caffeine systems.
C. Other molecules
To obtain a thermal equilibrium binding structure, we similarly set the initial locations
of other molecules in close proximity to the binding site of theophylline for preconditioning
MD simulations because the electrostatic potential surface of each molecule is almost the
same as theophylline. The obtained stable atomic configurations of other molecules bound
with RNA were virtually unchanged. The association of RNA with all six ligands is driven
primarily by attractive van der Waals interactions ∆GLJ as tabulated in Table II. The results
of the absolute and relative binding free energies we obtained for six ligands are given in
Table III, which also tabulates the results of other methods, TI and MM-PBSA [27] and
includes three important characteristics: 1) There is an effective linear relation (slope= 1)
between the computed absolute binding free energies and experimental ones. We obtained
the following relation between the computed relative energies ∆∆Gcalc and experimental ones
∆∆Gexpt for three different methods (the results of TI and MM-PBSA were from Ref. [27]):
∆∆Gcalc = ∆∆Gexpt−0.1, R = 0.99 (This work), ∆∆Gcalc = ∆∆Gexpt+0.19, R = 0.97 (TI),
∆∆Gcalc = ∆∆Gexpt + 1.68, R = 0.78 (MM-PBSA), where R is the correlation coefficient.
Consequently, the efficiencies of both our method and the TI method for estimating the
relative binding free energies are virtually comparable. Here, we should point out that
our method directly estimate the absolute binding energies, whereas the TI method only
compute the relative binding energies. We also point out that the absolute binding free
energy for the RNA-hypoxanthine system is partly shifted about 1.5 kcal/mol from the
linear relation, which means this result might suggest consideration be taken of another
binding site for hypoxanthine binding. 2) There is a constant energy shift of ∼ -7 kcal/mol
from the experimental values ∆Gexpt as can be seen in Fig. 5. Detailed discussions for the
latter are given below.
In general, since water molecules play an important role in free energy calculation, we have
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performed calculations of ∆Ulocal as the sum of short-range electrostatic interaction energy
and van der Waals interaction energy between RNA and ligand. The sample averaged values
during 1 ns MD simulations after reaching the thermal equilibrium state are shown in Fig. 6.
In comparison with Fig. 5, our method can reproduce the trend in both 1-methylxanthine
and xanthine well, although the large shift (≃ 2 kcal/mol) from a linear relation between
∆Ulocal and ∆Gexpt was evident. Consequently, our method evidently takes the effect of
water molecules into consideration.
D. Constant energy shift
The computed absolute binding free energies were approximately -7 kcal/mol smaller than
those obtained by the experiment. How do we solve the puzzle underlying the difference
between them? We briefly comment on the presumed reasons to solve this puzzle. First, it is
well known that nucleic acid, e.g. RNA or DNA, is generally flexible in solution [47]. There
are a number of metastable states in free energy space and long term residence at a single
valley, resulting in anomalously slow dynamics. Namely, the ensemble average of several
capable atomic structures was observed in the experiment. Thus, in the RNA-theophylline
system we examined exploration of another metastable structure using a simulated annealing
technique as follows: We first prepared a slightly expanded unit cell that was sufficient
to treat the RNA relaxing. Theophylline and RNA aptamer was solvated in a truncated
octahedron box with 3 Mg2+ ions, 26 Na+ counter-ions and 9325 TIP3P water molecules.
Next, energy minimization and position restrained MD simulation were carried out in the
same manner, as described in II. We also set a simulation temperature of 398 K to disturb the
stable complex structure during the simulation time of 100 ps. Consequently, a (meta)stable
atomic configuration was obtained by annealing to 298 K. One of the characteristic features
was that a Mg2+ ion leave from the center of the U-turn of C22-U24. Binding free energy of -
3.3 kcal/mol was obtained by AR analysis with simulation of up to 1 ns MD, by discarding the
first 400 ps runs, which is significantly small compared with the strongly binding structure
described in Sec. IIIA. The feature of convergence of the free energy estimation as a function
of the MD step for this weakly binding structure was also drawn in Fig. 3. We further divide
the binding free energy into electrostatic and van der Waals components. Binding free
energy of -0.4 kcal/mol is contributed from the electrostatic part, whereas, -3.0 kcal/mol
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is contributed from the van der Waals part. Second, we examined the influence of the
atomic charges of the ligand. Here, AM1-BCC charges [48] of the ligand generated from
MOPAC2002 were tested. ∆GSolv of -17.7 kcal/mol was obtained, while ∆GComplex of -
33.7 kcal/mol was also obtained up to 1 ns MD simulations. Both values increased by ∼
3 kcal/mol as compared to those using RESP charges; hence we obtained binding energy
of -15.9 kcal/mol, which is very close to the value of -16.1 kcal/mol using RESP charges.
Third, the convergence of binding energy was explored. The solvation energy ∆GLJSolv was
reduced by approximately 0.5 kcal/mol as the cutoff radius was increased from 0.9 nm to
1 nm. The ∆GLJComplex was also reduced by 0.2 kcal/mol as the cutoff radius increased from
0.9 nm to 1 nm, meaning the correction is substantially only 0.3 kcal/mol. Fourth, we
previously reported that ∼ 3 kcal/mol energy shift from the experimental values is existed
in FKBP12-ligand system [25]. Then, several researchers have tried to solve this issue
by different approaches [49, 50, 51]. Currently, we believe that this energy shift can be
interpreted by the difference of the force field used. The energy shift vanishes when we use
the GAFF for representing the potential of the protein to further improve the consistency.
Therefore, we examined computing the binding energy using GAFF representing all atoms
in the RNA-theophylline system. ∆GSolv of -14.2 kcal/mol was obtained, while ∆GComplex
of -27.0 kcal/mol was also obtained, so we obtained a free energy difference ∆G of -12.8
kcal/mol. This value still represents an approximate shift from the experimental values by
4.0 kcal/mol. Finally, since an RNA has significant negative charges, we believe the fact
that the charge polarizability of an atom is influenced by electrostatic interactions with its
surrounding atoms, becomes important [52, 53, 54]. For this reason the polarizable potential
model might be considered, however, as the computational cost rises significantly, we have
not yet examined this ability. Consequently, this puzzle remains a major challenge in the
RNA-ligand system.
IV. CONCLUSION
In conclusion, we have introduced the method (MP-CAFEE) as a highly accurate means
of obtaining the absolute binding free energy. This method has been applied to investi-
gate the properties of the RNA-ligand system. Since our method is suitable for the use
of many compute nodes, we have also developed a massively parallel computing system to
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effectively accelerate simulations. To further reduce the computational cost, we determined
the adequate non-uniform intervals of two coupling constants and consequently obtained
the following details: First, our estimated absolute binding free energies correlate well in
terms of a linear fit to the experimental values when all ligands are assumed to be preferable
to bind the same binding pocket. By comparing the results of two other methods, TI and
MM-PBSA[27], the accuracy of this method is almost comparable to that of TI in terms of
relative binding free energy. With this in mind, we believe this method to be a promising
tool to quantitatively predict the absolute binding free energy in the drug design domain.
Second, we expect a considerable difference in the binding affinity to RNA between theo-
phylline and caffeine to be attributed to the difference in hydrogen bonds of the related
environment by analyzing the free energy component. Finally, we find the constant energy
of ∼ -7 kcal/mol shifted from the experimental values for all ligands on absolute binding free
energy. Though considering several presumable solutions to this problem, this area remains
incompletely understood.
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TABLE I: Obtained free energy differences and rms values comparing with well-converged values
using condensed equal λ spacings, 20 uniformed points for λC, and 40 uniformed points for λLJ
respectively. These values are deduced from the first 100 ps MD trajectory.
solvation complex
N δGa rms δGa rms
λC 2 -0.14 0.09 0.08 0.18
5 0.11 0.09 0.10 0.14
10 0.03 0.03 0.06 0.07
11b 0.03 0.03 -0.01 0.03
λLJ 2 -6.45 3.73 -10.20 5.89
5 -2.69 1.16 -2.42 1.19
10 -0.28 0.13 -1.48 0.60
20 0.11 0.09 0.27 0.13
20b 0.05 0.08 -0.05 0.05
aδG ≡ ∆G−∆G0, where ∆G0 is well-converged value.
bThese values are obtained using an adaptive λ spacing set (see, in II).
TABLE II: Electrostatic contributions and those of van der Waals, decomposed from obtained
binding free energies for each RNA-ligand complex.
∆GSolv ∆GComplex ∆G
Ligand ∆GCSolv ∆G
LJ
Solv ∆G
C
Complex ∆G
LJ
Complex ∆G
C ∆GLJ
Theophylline -14.2 -0.2 -19.2 -11.3 -5.0 -11.1
3-Methylxanthine -16.8 -0.5 -22.1 -9.9 -5.3 -9.4
Xanthine -19.1 -1.0 -24.8 -10.0 -5.7 -9.0
1-Methylxanthine -16.7 -0.6 -21.3 -10.2 -4.6 -9.6
Hypoxanthine -18.2 -0.3 -22.8 -7.2 -4.6 -6.9
Caffeine -12.7 0.3 -13.1 -10.3 -0.4 -10.6
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TABLE III: Absolute binding free energies obtained for RNA aptamer and theophylline and its
analogs in kcal/mol.
Experimenta TIb MM-PBSAb This work
Ligand ∆Gexp ∆∆Gexp ∆∆Gbind ∆G(MM+solv) ∆∆G(MM+solv) ∆Gcalc ∆∆Gcalc
Theophylline -8.85 0 0 -18.51 0 -16.1 0
3-Methylxanthine -7.77 1.08 1.36 -15.27 3.25 -14.7 1.4
Xanthine -6.91 1.94 1.64 -12.97 5.54 -14.6 1.6
1-Methylxanthine -6.88 1.97 1.82 -14.24 4.27 -14.2 1.9
Hypoxanthine -5.87 2.98 — — — -11.6 4.5
Caffeine -3.35 5.50 6.63 -12.67 5.84 -11.0 5.1
aThese values are obtained using the formula -RT lnKd, whereKd is the individual competitor dissociation
constant. [45]. T=298 K.
bThese values are from Ref. 27.
17
-20
-15
-10
-5
0
0 0.2 0.4 0.6 0.8 1
∆
G
C  
(λ C
) (
kc
al
/m
ol
)
λC
Solv
Complex
-20
-15
-10
-5
0
0 0.2 0.4 0.6 0.8 1
∆
G
LJ
 
(λL
J ) 
(kc
a
l/m
ol
)
λ
LJ
Solv
Complex
(a)
(b)
FIG. 1: Free energy convergence as a function of the number of λ spacing for the RNA-Theophylline
system; (a) ∆GC vs. λC. Open symbols are our reduced 12 λC points of (0, 0.1, 0.25, 0.45, 0.55,
0.65, 0.7, 0.75, 0.8, 0.9, 0.95, 1). The solid lines are generated from 20 uniform mesh points of λC.
(b) ∆GLJ vs. λLJ. Open symbols are our reduced 21 λLJ points of (0, 0.1, 0.2, 0.275, 0.375, 0.45,
0.55, 0.65, 0.675, 0.725, 0.75, 0.775, 0.8, 0.825, 0.85, 0.875, 0.9, 0.925, 0.95, 0.975, 1), while the
solid lines are generated from 40 uniform mesh points of λLJ.
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FIG. 2: Chemical structures of ligands investigated. The dissociation constant Kd (in µM) is
included in each parenthesis. The electrostatic potential surfaces of molecules are also shown with
red representing the negative potential and blue representing the positive potential respectively (-4
kBT/e to 4 kBT/e).
19
E
n
e
rg
y
 (
k
c
a
l/
m
o
l)
-20
-18
-16
-14
-12
-10
(a)
(b)
-40
-35
-30
-25
-20
-15
0 200 400 600 800 1000
MD step (ps)
Strongly bound
Weakly bound
FIG. 3: Free energy of theophylline-RNA aptamer as a function of MD step: (a) ∆GSolv for solvated
theophylline, (b) ∆GComplex for the RNA-theophylline complex. Open circle denotes a strongly
binding structure, while the open square denotes a weakly binding structure (see, in IIID). Error
bars in both graphs are drawn from the maximum value to minimum value.
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FIG. 4: (a) Theophylline molecule and its surroundings in the RNA-theophylline complex. Only
two residues related to hydrogen bonds are drawn and candidates for hydrogen bonds are depicted
as dashed lines. (b) Caffeine molecule and its surroundings in the RNA-caffeine complex, while
hydrogen bonds with residue in the same plane are also drawn in the form of a dashed line.
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FIG. 5: Computed binding free energies ∆Gcalc vs. experimentally measured binding free energies
∆Gexpt for six ligands. The line of slope= 1 is also drawn as a guide. The abbreviations used here
are TEP as theophylline, TME as 3-methylxanthine, XAN as xanthine, OME as 1-methylxanthine,
HXA as hypoxanthine and CAF as caffeine.
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FIG. 6: Local potential energies computed ∆Ulocal vs. experimental binding free energies ∆Gexpt
for six ligands. The line of slope= 1 is also drawn as a guide, while the abbreviations used are the
same as those in Fig. 5.
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